We are live on
!
Find out more
LP
LMR Partners Portfolio holdings
AUM
$45.4B
1-Year Est. Return
60.68%
This Fund
S&P 500
This Quarter
Est. Return
+17.46%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$14B
AUM Growth
+$3.28B
(+31%)
Cap. Flow
+$324M
Cap. Flow
% of AUM
2.32%
Top 10 Holdings %
Top 10 Hldgs %
24.44%
Holding
1,743
New
418
Increased
280
Reduced
331
Closed
391
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares National Muni Bond ETF
MUB
|
+$176M |
| 2 |
Infosys
INFY
|
+$102M |
| 3 |
K
Kellanova
K
|
+$74.6M |
| 4 |
Amazon
AMZN
|
+$58.6M |
| 5 |
Alibaba
BABA
|
+$52.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$114M |
| 2 |
HDFC Bank
HDB
|
+$97.7M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$55.3M |
| 4 |
Roper Technologies
ROP
|
+$45.7M |
| 5 |
Nutanix
NTNX
|
+$44.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.38% |
| 2 | Financials | 4.13% |
| 3 | Consumer Discretionary | 2.33% |
| 4 | Communication Services | 2.26% |
| 5 | Healthcare | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Immunovant
IMVT
$8.09B
| $401K | ﹤0.01% |
+25,067
| New | +$379K |
|
952
BlackSky Technology Inc Warrants
BKSY.WS
$938K
| $400K | ﹤0.01% |
1,353,603
| – | – |
|
953
CALL
Lowe's Companies
LOW
$116B
| $399K | ﹤0.01% |
+1,800
| New | +$402K |
|
|
954
PUT
Lowe's Companies
LOW
$116B
| $399K | ﹤0.01% |
+1,800
| New | +$402K |
|
955
CALL
KKR & Co
KKR
$89.2B
| $399K | ﹤0.01% |
+3,000
| New | +$351K |
|
956
Netflix
NFLX
$292B
| $398K | ﹤0.01% |
2,970
-40,530
| -93% | -$4.58M |
|
|
CNCKW
957
Coincheck Group Warrant expiring 12/10/2029
CNCKW
| $398K | ﹤0.01% |
457,003
| – | – |
|
958
TripAdvisor
TRIP
$1.59B
| $392K | ﹤0.01% |
30,005
-211,990
| -88% | -$2.83M |
|
959
ASML
ASML
$675B
| $390K | ﹤0.01% |
487
+345
| +243% | +$248K |
|
960
CALL
Lamb Weston
LW
$6.82B
| $384K | ﹤0.01% |
+7,400
| New | +$396K |
|
|
FLDDW
961
Fold Holdings Warrant
FLDDW
$1.3M
| $382K | ﹤0.01% |
538,182
| – | – |
|
962
CALL
T-Mobile US
TMUS
$193B
| $381K | ﹤0.01% |
1,600
-5,200
| -76% | -$1.27M |
|
963
Madrigal Pharmaceuticals
MDGL
$12.6B
| $376K | ﹤0.01% |
1,242
| – | – |
|
964
CALL
Halliburton
HAL
$27.9B
| $369K | ﹤0.01% |
18,100
+15,100
| +503% | +$317K |
|
965
Republic Services
RSG
$66.7B
| $369K | ﹤0.01% |
+1,495
| New | +$369K |
|
966
Martin Marietta Materials
MLM
$33.6B
| $368K | ﹤0.01% |
+671
| New | +$355K |
|
|
CFLT
967
PUT
DELISTED
Confluent
CFLT
| $366K | ﹤0.01% |
14,700
-100
| -0.7% | -$2.25K |
|
968
PUT
Waste Management
WM
$95.9B
| $366K | ﹤0.01% |
+1,600
| New | +$371K |
|
969
Realty Income
O
$61.2B
| $365K | ﹤0.01% |
6,337
+2,406
| +61% | +$136K |
|
970
CALL
Domino's
DPZ
$11B
| $360K | ﹤0.01% |
+800
| New | +$376K |
|
971
WEC Energy
WEC
$37.7B
| $360K | ﹤0.01% |
+3,455
| New | +$368K |
|
|
RDAGW
972
Republic Digital Acquisition Co Warrants
RDAGW
| $360K | ﹤0.01% |
+500,000
| New | +$434K |
|
973
Target
TGT
$62.1B
| $360K | ﹤0.01% |
3,646
-17,024
| -82% | -$1.63M |
|
974
Oric Pharmaceuticals
ORIC
$1.25B
| $358K | ﹤0.01% |
35,267
-33
| -0.1% | -$222 |
|
975
BigBear.ai
BBAI
$1.32B
| $358K | ﹤0.01% |
+52,697
| New | +$190K |
|
Similar funds
AS
TI
LMR Partners's Q2 2025 Portfolio in Review
As of Q2 2025, LMR Partners held 1,743 positions worth $14B, up 31% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
LMR Partners's Q2 2025 filing shows 418 new, 280 increased, 331 reduced and 391 closed positions. Its largest new stake was Infosys: 5,733,005 shares worth $106M. The largest sale was Intra-Cellular Therapies Inc., an estimated $114M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 11% a quarter earlier, followed by Financials and Consumer Discretionary.
- LMR Partners's largest Q2 2025 buy was Infosys: 5,733,005 shares worth $106M.
- LMR Partners added most to iShares National Muni Bond ETF in Q2 2025, an estimated $176M increase.
- LMR Partners's biggest Q2 2025 reduction was Roper Technologies, cutting an estimated $45.7M.
- LMR Partners fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $114M.
- LMR Partners's ten largest holdings make up 24% of its $14B portfolio in Q2 2025.
- LMR Partners opened 418 new positions and closed 391 in Q2 2025.
- LMR Partners's portfolio value rose 31% quarter-over-quarter to $14B.
Based on LMR Partners's 13F filing for Q2 2025, filed 14 Aug 2025.